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Summary A recent trial by the MRC Lung Cancer Working Party used physician assessments to compare
two palliative schedules of radiotherapy in lung cancer. A prospective study has been undertaken on a subset
of these trial patients to see how physician assessments of symptomatic relief and general condition correlate
with patient perception of therapeutic response. In 40 patients followed up monthly from presentation until
close to death, good agreement was found between doctors and patients on change in specific physical
symptoms and overall physical condition. Doctors were poor judges of life quality at presentation but
appeared able to identify relative improvement or deterioration in overall quality of life. In conclusion,
physician assessments may constitute valid end-points for radiotherapy trials comparing palliative schedules in
lung cancer.
Radiotherapy is often used of the palliation of respiratory
systems and pain in patients with inoperable non-small cell
lung cancer (NSCLC) but published data relating to treat-
ment benefit are based on retrospective physician assessments
of individual symptoms rather than on prospective patient
self-assessments (Deeley et al., 1967; Durrant et al., 1971;
Slawson et al., 1979; Simpson et al., 1985).
A recent trial by the MRC Lung Cancer Working Party
compared two schedules of palliative radiotherapy (ten
treatments vs two treatments) in symptomatic patients. The
results were based on physician ratings of symptomatic relief
and detected no differences in treatment outcome (Lung
Cancer Working Party, 1991). However, it is unclear how
well physician ratings of response correlate with patients'
views of treatment benefit. In an attempt to measure the
utility of physician ratings as a basis for comparing palliative
radiotherapy schedules in lung cancer, a prospective study
was undertaken of physician and patient assessments before
and after radiotherapy for lung cancer.
Patients and methods
Patient and treatment characteristics
Patients were referred following bronchoscopy to the Joint
Chest Clinic, at St Helier Hospital, where they were
examined by a Consultant Chest Physician (N.T.C. or
P.W.J.) and Consultant Radiotherapist and Oncologist
(J.R.Y.). Investigations included a clinical examination, FBC
and chest radiograph.
Forty patients with cytologically or histologically proven
NSCLC requiring palliative radiotherapy were entered into
this study (33 males, seven females; median age 68 years,
range 46-82 years). Thirty-one patients had no signs of
extra-thoracic disease at presentation. All patients agreed to
be randomised into the MRC palliative radiotherapy trial.
They received either 30 Gy in ten fractions over 12 days (20
patients) or 17 Gy in two fractions over 8 days (20 patients)
delivered as a mid-plane dose by antero-posterior fields to the
thorax encompassing all radiologically visible tumour.
Questionnaires
Physicians and patients completed separate questionnaires at
presentation and at monthly clinic attendances thereafter. At
each visit, the physician assessment was made either by a
consultant chest physician or by a radiotherapist. The
physician and patient did not see each other's responses, nor
their own previous scores. The physician questionnaire used
in the MRC palliative radiotherapy trial rated the ECOG
performance status, MRC scale of general condition and
MRC dyspnoea score on five point graded scales (see Appen-
dix I). Specific symptoms including cough, haemoptysis and
chest pain were rated on a four point graded scale. Doctors
were also asked to assess how patients felt compared to their
previous attendance viz, better, same or worse.
For the self-assessments, patients were interviewed by a
Research Assistant (J.R.) in a separate room adjacent to the
clinic, where they completed the EORTC Quality of Life
Questionnaire. This included 36 questions relating to physical
and mental state including specific symptoms such as short-
ness of breath and global questions including 'How would
you rate your overall physical condition during the past
week?' and 'How would you rate your overall quality of life
during the past week?' The questionnaire used the predated
modular form currently under evaluation (Aaronson et al.,
1988). The first visit lasted anything up to 1 h, giving the
patient ample opportunity to express him or herself and to
become familiar with the structure of the questionaire. Every
patient complied fully at every clinic visit where they spent as
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Figure 1 Follow-up of patients in assessment protocol compared
to overall survival in 40 patients. A = Follow-up; 0 = survival.
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much time as they needed with the research assistant to
complete their questionnaires. The results of the EORTC
Quality of Life Questionnaire were not seen by the clinical
staff.
Analysis
All items of the MRC physician questionnaire were utilised,
whereas specific items related to breathlessness, overall
physical condition and overall life quality were selected from
the EORTC patient questionnaire. Analyses of treatment
responses were based on the relative change in scores com-
pared to the time of presentation. This overcomes a potential
source of bias in reporting absolute scores whereby apparent
improvements in symptomatology might be accounted for by
deaths in the worst affected patients.
ECOG Performance
Status
Results
Duration offollow up
Patients were followed close to the time of death, see Figure
1. The median time to death from final clinical assessment
was 30 days (range 4-78 days).
Assessments at presentation
The patient assessments of overall life quality at presentation
are shown in Figure 2. Patients scored their breathlessness at
presentation as 'Not at all' (eight patients), 'A little' (eight
patients), 'Quite a bit' (15 patients) and 'Very much' (nine
patients). Physician scores for ECOG performance status,
MRC general condition and MRC dyspnoea grade are sum-
marised in Figure 3.
Correlation between physician and patient assessments at
presentation
None of the physician assessments correlated with patient
self-ratings of overall life quality (Table I). On the other
hand, there were significant correlations between patient self-
assessments of overall physical condition and physician
assessments of physical performance, general condition,
dyspnoea (Table I). Patient self-ratings of overall life quality
did not correlate with any of the physician assessments
(Table I). There was also a high correlation between patient
self-assessments of overall life quality and overall physical
condition (r = 0.74; P < 0.001).
Physician assessment of treatment response
Physicians recorded no change in ECOG performance status,
MRC general condition or MRC dyspnoea grade in the
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Figure 2 Distribution of scores for patients' rating of overall
quality of life in 40 patients at presentation.
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Figure 3 Distribution of scores for the physicians' scores for
ECOG performance status, MRC general condition and MRC
dyspnoea grade in 40 patients at presentation.
Table I Spearman correlations between physician assessments of
general condition and patient assessments of overall physical
condition and life quality at presentation
Patient self-assessments
Physician EORTC overall EORTC overall
assessments physical condition life quality
ECOG performance rs = 0.43 (P = 0.007) rs = 0.17 (P = 0.3)
status
MRC general rs = 0.47 (P = 0.004) rs = 0.17 (P = 0.3)
condition
MRC dyspnoea rs = 0.44 (P = 0.005) r, = 0.28 (P = 0.1)
grade
(rs= Spearman correlation coefficient).
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Figure 4 Changes in ECOG performance status, MRC general
condition and MRC dyspnoea grade at 1 and 3 months following
radiotherapy. M = 1 month; MI = 3 months.
majority of patients at 1 month following radiotherapy
(Figure 4). In those patients surviving to 3 months, over 40%
were judged to have improved in terms of performance status
and general condition, although few were judged to be less
breathless (Figure 4). In contrast, improvements in specific
symptoms were recorded at 1 month and at 3 months (Figure
5).
Patient's assessments of treatment response
Scores for overall life quality and overall physical state
showed an improvement in about half of the patients 1
month after presentation, while just under a quarter showed
a deterioration (Figure 6). There was a small but significant
association between changes in the patient assessments of
breathlessness and changes in patient assessments of overall
life quality (Table II).
Relationship between changes in physician and patient
assessments after I month
Physician ratings of overall condition judged from the ques-
tion 'Does the patient in general feel better, the same, or
worse than at last attendance?' are displayed in Figure 6.
Responses to this question showed a pattern of change
similar to that obtained from the patient assessment of
change in overall life quality and overall physical state
(Figure 6).
Change in the patient ratings of overall life quality was
significantly associated with physician assessments of 'how
the patient feels compared to the last visit' (Table III).
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Figure 5 Changes in haemoptysis, cough and chest pain at and 3
months following radiotherapy. _ = month; = 3 months.
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Figure 6 Changes in overall life quality and physical condition
rated by the patients together with changes in MRC grade for
general condition rated by their physicians over 1 month follow-
ing radiotherapy. _ = Life quality (patient): 1 = physical
condition (patient); = overall condition (physician).
Changes in the patient self-assessment of breathlessness were
significantly related to changes in the physician assessments
of MRC respiratory status at 1 month, but not with change
in physician ratings of ECOG performance status (Tables IV
and V).
Discussion
A recent trial by the MRC Lung Cancer Working Party
found no difference in palliative effect between 30 Gy in ten
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Table II Relationship between the changes in the patient
assessments of breathlessness and overall life quality at 1 month
Patient assessment of breathlessness
Improved Unchanged Worse Total
Patient Improved 10 4 2 16
assessment Unchanged 4 7 3 14
of life Worse 1 1 4 6
quality Total 15 12 9 36
(Figures are patient numbers, x2 = 10.38, P = 0.035).
Table III Relationship between physician ratings of change in 'how
patient feels' and patient assessments of overall life quality at 1
month
Physician rating of how patient feels
Improved Same Worse Total
Patient Improved 14 4 0 18
rating Same 7 3 1 17
of life Worse 1 4 2 7
quality Total 22 11 3 36
(Figures are patient numbers, x2 = 10.36, P = 0.035).
fractions and 17 Gy in two fractions to the thorax in patients
with incurable non-small cell lung cancer (Bleehen et al.,
1990). The main comparisons were based on monthly assess-
ments of symptoms and performance status as recorded by
their physicians. The present study was undertaken on a
subset of the MRC trial patients to test whether ratings by
physicians provided a reliable measure of the patient's sub-
jective state of health in a trial of palliative radiotherapy.
This was done by comparing physician ratings and patient
self-assessments of therapeutic response.
The pre-treatment characteristics of 40 patients in the cur-
rent study were comparable to 369 patients randomised in
the MRC study: males 82% (MRC 78%), median age 68
years (MRC 68 years), distant metastases 23% (MRC 32%),
ECOG performance status 0 or 1 61.5% (MRC 51%),
haemoptysis 42.5% (MRC 46.5%), cough 90% (MRC 92.5%),
chest pain 37.5% (MRC 46.5%). In our patients, physicians
scored improved ratings for haemoptysis in 75% (MRC
81%), cough in 50% (MRC 65%) and chest pain in 80%
(MRC 75%). The median survival was 22 weeks, compared
with 24 weeks for patients in the MRC study. Our study
population appears, therefore, to have been a representative
sub-set of the patients in the whole study. The mortality rate
in the study severely limited the time period over which
comparisons could be made between physicians' and patients'
estimates of the patients' health. We have mainly concen-
trated on changes over the first month of follow-up after
treatment.
At presentation, there was significant agreement between
the patient assessments of overall physical condition and the
physician assessments of ECOG performance status, MRC
general condition and MRC respiratory status (Table II).
Similarly, there was a signficant agreement between change in
respiratory status assessed by the physicians using the MRC
dyspnoea scale and change in breathlessness scored by the
patients using the EORTC questionnaire (Table III). In con-
trast, there was poor agreement at presentation between the
patient assessments of overall life quality and any of the
physician assessments (Table I). Furthermore, changes in
Table IV Patient/physician assessments of changes in breathlessness/
dyspnoea at I month
Physician assessment of MRC
respiratory status
Improved No change Worse Total
Patient Improved 12 5 0 17
assessment No change 1 6 4 11
of Worse 4 1 3 8
breathlessness Total 17 12 7 36
(Figures are patient numbers, x2 = 14.2, P = 0.007).
Table V Relationship of patient assessment of changes in life
quality to changes in ECOG performance status at 1 month
ECOG performance status
Improved Same Worse Total
Patient Improved 2 10 4 16
rating Same 5 6 2 13
of life Worse 2 4 1 7
quality Total 9 20 7 36
(Figures are patient numbers, x2 = 2.78, P = 0.6).
patient rating of overall life quality did not correlate with
changes in the physician assessments, such as ECOG perfor-
mance status (Table V).
The inability of physicians to accurately estimate the life
quality of their patients has been previously reported (Slevin
et al., 1988). In our study, the data presented in Table IV
shows a weak, but significant correlation between patient
ratings of changes in overall life quality at 1 month com-
pared with physician ratings of 'how the patient feels com-
pared to the last visit'. These data may be interpreted to
suggest that physicians were able to recognise relative change
in life quality. The reason for this apparent sensitivity to
changes in the patients' overall life quality may be related to
a particular item in the MRC questionnaire completed by
physicians. The form of this item 'how the patient feels
compared to the last visit' (the same, better or worse) is
unique in terms of its global nature relative to other assess-
ments such as ECOG performance status and MRC respir-
atory scale. The physician is able to gather information
about how the patient actually feels by asking the question
directly. More work is needed to find out if this particular
assessment correlates well with patient self-assessments of
change in life quality.
In conclusion, this small but detailed study suggests there
is reasonable agreement between doctors and patients on the
latter's overall physical condition at the time of presentation
with inoperable NSCLC. There was also a measure of agree-
ment concerning changes in these parameters. The study
suggests that physicians are poor judges of the overall life
quality of their patients at presentation. Physicians do appear
to have some measure of success in detecting relative changes
in patient overall life quality following palliative radiotherapy
although this may rely heavily on the nature of a particular
questionnaire item. It is therefore reasonable to assume that
physician assessments of changes in specific symptoms and
physical status before and after treatment constitute valid
endpoints for radiotherapy trials comparing palliative
schedules in inoperable lung cancer.
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Appendix I
MRC Palliative Radiotherapy Study: summary of selected physician assessments
ECOG performance status MRC general condition Respiratory assessment
Normal activity without Excellent Climbs hills or stairs
restriction without dyspnoea
Strenuous activity restricted, Good Walks any distance on flat
can do light work without dyspnoea
Up and about > 50% of Fair Walks over 100 yards without
waking hours, capable of dyspnoea
self-care
Confined to bed or chair Poor Dyspnoea on walking 100 yards
50% of waking hours, or less
limited self-care
Confined to bed or chair, Very poor Dyspnoea on mild exertion,
no self-care, completely e.g. undressing
disabled
Four point graded scales (none, little, quite a bit, very much) applied to cough, haemoptysis,
pain in chest, anorexia, nausea, vomiting, difficulty in swallowing, sore throat, diarrhoea,
anxiety, depression and other (specify).
Does the patient in general feel better,
the same,
or worse than at the last attendance? _
